Majorly Resurgent and Uncontrolled Diabetes During COVID19 Era, and in the Future Can Be Contained in India.

Misra, Anoop

Misra, Anoop.

Misra A; National Diabetes, Obesity and Cholesterol Foundation (N-DOC), New Delhi, India; Diabetes Foundation (India), New Delhi, India; Fortis C-DOC Center for Excellence for Diabetes, Metabolic Diseases and Endocrinology, New Delhi, India. Electronic address: anoopmisra@gmail.com.

Diabetes Metab Syndr ; 15(5): 102142, 2021.

Article in English | MEDLINE | ID: covidwho-1245927

Subject(s)

COVID-19/complications; Diabetes Mellitus, Type 2/prevention & control; SARS-CoV-2/isolation & purification; COVID-19/transmission; COVID-19/virology; Diabetes Mellitus, Type 2/epidemiology; Diabetes Mellitus, Type 2/virology; Disease Management; Humans; India/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / SARS-CoV-2 / COVID-19 Type of study: Observational study Topics: Long Covid Limits: Humans Country/Region as subject: Asia Language: English Journal: Diabetes Metab Syndr Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google